Search

everythinglearnresearchcommunity

for

Search:↓

Testosterone replacement may help some postmenopausal women with symptoms like fatigue and low libido, but more research is needed to fully understand its effects.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

Finasteride improves hair loss in women with hyperandrogenism.

Eating 500 fewer calories a day and making lifestyle changes can improve PCOS symptoms and reduce diabetes risk; more research is needed on its causes and treatments.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Finasteride reduces hair growth better, but spironolactone has more side effects.

Hirsutism is excessive hair growth in women often caused by polycystic ovarian syndrome, and identifying the cause is important for managing associated health risks.

Postmenopausal frontal fibrosing alopecia is a type of hair loss in postmenopausal women that may stop on its own but has no effective treatment.

Low-level laser therapy may improve hair regrowth and thickness for androgenetic alopecia, but more research is needed.

New alopecia treatments aim for better results and fewer side effects.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

Finasteride 5 mg/day effectively treats hair loss in postmenopausal women without hyper-androgenism.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Doctors should know how to diagnose and treat PCOS, which often involves checking for high male hormone levels and using medications to manage symptoms.

Women with severe types of PCOS are more likely to have metabolic syndrome, and belly fat is a key predictor of this risk.

Finasteride effectively treats hair loss in transgender men with few side effects.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Understanding and tracking our body's natural daily rhythms could help improve heart health.

Finasteride may help some women with hair loss, but better options exist.

Women with PCOS have higher xanthine oxidase activity linked to inflammation and heart disease risks.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Oral contraceptives lower testosterone levels in women, especially those with certain genetic traits, and may be linked to increased breast cancer risk.

AR gene not major factor in female hair loss; different from male hair loss.